Alyeska Investment Group’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $329K | Buy |
+7,629
| New | +$329K | ﹤0.01% | 528 |
|
2025
Q1 | – | Sell |
-940,415
| Closed | -$25.8M | – | 512 |
|
2024
Q4 | $25.8M | Buy |
+940,415
| New | +$25.8M | 0.1% | 230 |
|
2019
Q3 | – | Sell |
-65,154
| Closed | -$1.76M | – | 372 |
|
2019
Q2 | $1.76M | Buy |
+65,154
| New | +$1.76M | 0.02% | 303 |
|